My WebMD Sign In

Please enter email address

Enter your password

Keep me signed in on this computer

Show more Information

If you select "Keep me signed in on this computer", every time you visit WebMD.com you won't have to type your email address and password. This means that a cookie will stay on your computer even when you exit or close your browser which may reduce your levels of privacy and security. You should never select this option if you're using a publicly accessible computer, or if you're sharing a computer with others. Even if you select this option there are some features of our site that still require you to log in for privacy reasons.

Forget your password? Having trouble signing in?

Why should I
sign up for WebMD?

With a WebMD Account you can:

Track your way to weight loss success
Manage your family's vaccinations
Join the conversation

See more benefits Sign Up

Why WebMD?

My WebMD

Show Menu

Facebook Twitter Pinterest

WebMD Home

Cancer Health Center

Cancer Related Topics

Email a Friend

Print Article

Cancer Health Center

Tools & Resources

Font Size

Treatment Options for Recurrent Salivary Gland Cancer

Treatment of recurrentsalivary gland cancer may include the following:

Radiation therapy.
A clinical trial of a new treatment.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent salivary gland cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Recommended Related to Cancer

Stage Information for Pheochromocytoma and Paraganglioma

There is no standard staging system for pheochromocytoma and paraganglioma. Patients have traditionally been divided into categories based on the presence of localized (apparently benign), regional, and metastatic disease. There are no clear data regarding the survival of patients with localized (apparently benign) disease or regional disease. Although patients with localized (apparently benign) disease should experience an overall survival approaching that of age-matched disease-free individuals,...

Read the Stage Information for Pheochromocytoma and Paraganglioma article > >

WebMD Public Information from the National Cancer Institute

Last Updated: October 07, 2011

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.